Dr Michael Winlo: Ledger

Stories naming Dr Michael Winlo. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

Role	Organisation	Sources
Managing Director	Emyria	Startup Daily

Unnamed stage $2.5m

Andrew Forrest doubles down on therapeutic ecstasy biotech Emyria

Therapeutic psychedelics biotech Emyria has banked $2.5 million via a share placement co-led by Sixty Two Capital and Taylor Collison, with follow-on from Andrew Forrest's Tenmile, funding MDMA- and psilocybin-assisted therapy and cannabinoid trials.

Startup Daily Mon 1 May 2023 Emyria Tattarang University of Western Australia Sixty Two Capital Taylor Collison Tenmile Dr Andrew Forrest Dr Michael Winlo

Dr Michael Winlo

Roles

Coverage

Andrew Forrest doubles down on therapeutic ecstasy biotech Emyria